» Articles » PMID: 33107762

Optimization of Viable Glioblastoma Cryopreservation for Establishment of Primary Tumor Cell Cultures

Overview
Publisher Mary Ann Liebert
Specialty Biotechnology
Date 2020 Oct 27
PMID 33107762
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Technologies related to the establishment of primary tumor cell cultures from solid tumors, including glioblastoma, are increasingly important to oncology research and practice. However, processing of fresh tumor specimens for establishment of primary cultures on the day of surgical collection is logistically difficult. The feasibility of viable cryopreservation of glioblastoma specimens, allowing for primary culture establishment weeks to months after surgical tumor collection and freezing, was demonstrated by Mullins et al. in 2013, with a success rate of 59% that was not significantly lower than that achieved with fresh tumor tissue. However, research targeting optimization of viable glioblastoma cryopreservation protocols for establishment of primary tumor cultures has been limited. The objective of this study was to optimize glioblastoma cryopreservation methods for viable cryobanking and to determine if two-dimensional (2D) or three-dimensional (3D) culture conditions were more supportive of glioblastoma growth after thawing of frozen tumor specimens. Portions of eight human glioblastoma specimens were cryopreserved by four different protocols differing in the time of enzymatic digestion (before or after cryopreservation), and in the type of cryopreservation media (CryoStor CS10 or 10% dimethyl sulfoxide and 90% fetal calf serum). After 1 month, frozen tissues were thawed, enzymatically digested, if not digested before, and used for initiation of 2D or 3D primary tumor cultures to determine viability. Among the tested cryopreservation and culturing protocols, the most efficient combinations of cryopreservation and culture were those associated with the use of CryoStor CS10 cryopreservation medium, enzymatic digestion before freezing, and 2D culturing after thawing with a successful culture rate of 8 out of 8 cases (100%). Two-dimensional cultures were in general more efficient for the support of tumor cell growth after thawing than 3D cultures. This study supports development of evidence-based viable glioblastoma cryopreservation methods for use in glioblastoma biobanking and research.

Citing Articles

Non-animal glioblastoma models for personalized treatment.

Zottel A, Jovcevska I, Samec N Heliyon. 2023; 9(10):e21070.

PMID: 37928397 PMC: 10622609. DOI: 10.1016/j.heliyon.2023.e21070.


Effect of cryopreservation on A172 and U251 glioma cells infected with lentiviral vectors designed for CRISPR/Cas9-mediated aquaporin-8 knock-out.

Zhang H, Zhu S, Xing Y, Liu Q, Guo Z, Cai Z PLoS One. 2022; 17(3):e0263162.

PMID: 35245307 PMC: 8896708. DOI: 10.1371/journal.pone.0263162.


Assessment of the Impact of Post-Thaw Stress Pathway Modulation on Cell Recovery following Cryopreservation in a Hematopoietic Progenitor Cell Model.

Baust J, Snyder K, Van Buskirk R, Baust J Cells. 2022; 11(2).

PMID: 35053394 PMC: 8773610. DOI: 10.3390/cells11020278.

References
1.
Rajaratnam V, Islam M, Yang M, Slaby R, Ramirez H, Mirza S . Glioblastoma: Pathogenesis and Current Status of Chemotherapy and Other Novel Treatments. Cancers (Basel). 2020; 12(4). PMC: 7226351. DOI: 10.3390/cancers12040937. View

2.
Clarke D, Yadock D, Nicoud I, Mathew A, Heimfeld S . Improved post-thaw recovery of peripheral blood stem/progenitor cells using a novel intracellular-like cryopreservation solution. Cytotherapy. 2009; 11(4):472-9. PMC: 3021966. DOI: 10.1080/14653240902887242. View

3.
Ivanics T, Bergquist J, Liu G, Kim M, Kang Y, Katz M . Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant type. Lab Invest. 2018; 98(7):947-956. PMC: 6072591. DOI: 10.1038/s41374-018-0042-7. View

4.
Friedrich M . Studying cancer in 3 dimensions: 3-D models foster new insights into tumorigenesis. JAMA. 2003; 290(15):1977-9. DOI: 10.1001/jama.290.15.1977. View

5.
Omuro A, DeAngelis L . Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013; 310(17):1842-50. DOI: 10.1001/jama.2013.280319. View